These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Effect of the unclamped umbilical cord on the feto-maternal microtransfusion]. Wein N; Schneider I Zentralbl Gynakol; 1970 Aug; 92(34):1113-7. PubMed ID: 4995979 [No Abstract] [Full Text] [Related]
65. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion]. Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413 [No Abstract] [Full Text] [Related]
66. [Prevention of rhesus-immunization]. Dano P Nord Med; 1969 Feb; 81(7):220-1. PubMed ID: 4183685 [No Abstract] [Full Text] [Related]
67. [Problems of IgG-anti D administration during pregnancy]. Hähn N; Gallasch EH; Smaluhn W; Lüthje D Zentralbl Gynakol; 1974 Jul; 96(29):897-904. PubMed ID: 4213693 [No Abstract] [Full Text] [Related]
69. [Demonstration and elimination of HbF cells in mothers after the birth of ABO-incompatible children]. Luboldt W Bibl Haematol; 1969; 32():312-8. PubMed ID: 4981567 [No Abstract] [Full Text] [Related]
70. [Immunological aspects of the prevention of hemolytic disease of the newborn]. Antonian AK Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267 [No Abstract] [Full Text] [Related]
71. [The problem of antibody control during the first days after anti-D prophylaxis]. Ennker J; Maas DH; Schneider J Fortschr Med; 1978 Sep; 96(33):1650-6. PubMed ID: 100401 [No Abstract] [Full Text] [Related]
72. Irregular antibodies in the obstetric patient. Queenan JT; Smith BD; Haber JM; Jeffrey J; Gadow HC Obstet Gynecol; 1969 Dec; 34(6):767-71. PubMed ID: 4983579 [No Abstract] [Full Text] [Related]
73. [Immunological problems in feto-neonatal hemolytic disease caused by Rh isoimmunization]. Di Stefano M; Cardone A Arch Ostet Ginecol; 1968; 73(1):84-93. PubMed ID: 4188546 [No Abstract] [Full Text] [Related]
74. [Obstetrical management in the prevention of Rh factor immunization]. Medina Aguilar R Ginecol Obstet Mex; 1969 Mar; 25(149):257-66. PubMed ID: 4181035 [No Abstract] [Full Text] [Related]
75. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage]. Mattone PG; Meriggi E; De Martin G Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573 [No Abstract] [Full Text] [Related]
76. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization]. Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A Arch Ostet Ginecol; 1969 Dec; 74(6):476-94. PubMed ID: 5000274 [No Abstract] [Full Text] [Related]
77. [A trial of suppression of Rh antibody production by i.v. administration of Gammavenin]. Preisler O; Hummel K Geburtshilfe Frauenheilkd; 1966 Aug; 26(8):1173-8. PubMed ID: 4170109 [No Abstract] [Full Text] [Related]
78. [Actual possibilities of prevention of serologic incompatibility]. Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438 [No Abstract] [Full Text] [Related]
79. [Placenta and maternal and fetal iso-immunization]. von Muralt G Geburtshilfe Frauenheilkd; 1972 Feb; 32(2):81-8. PubMed ID: 4622621 [No Abstract] [Full Text] [Related]
80. [Rhesus immunoprevention by means of immunoglobulin anti-D]. Maas DH; Schneider Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]